Profile data is unavailable for this security.
About the company
Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing disease modifying treatments for neurodegenerative diseases. The Company’s lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. It has the potential to treat Parkinson’s disease, as well as various Parkinsonian disorders, such as Multiple System Atrophy (MSA). The Company also has a drug discovery platform generating patentable chemical compounds to intercede in disease processes. ATH434 has been granted Orphan designation for the treatment of MSA. The Phase 2 clinical trial is a randomized, double-blind, placebo-controlled investigation of ATH434 in patients with early-stage MSA.
- Revenue in USD (TTM)81.58k
- Net income in USD-8.12m
- Incorporated1997
- Employees11.00
- LocationAlterity Therapeutics LtdL 3 460 Bourke StMELBOURNE 3000AustraliaAUS
- Phone+61 39349-4906
- Fax+61 39822-7735
- Websitehttps://alteritytherapeutics.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Minerva Neurosciences Inc | 0.00 | -31.60m | 16.57m | 9.00 | -- | -- | -- | -- | -4.48 | -4.48 | 0.00 | -5.23 | 0.00 | -- | -- | 0.00 | -61.90 | -49.89 | -65.32 | -52.39 | -- | -- | -- | -442.65 | -- | -- | -- | -- | -- | -- | 6.55 | -- | -- | -- |
| Cocrystal Pharma Inc | 0.00 | -17.98m | 16.58m | 12.00 | -- | 0.6286 | -- | -- | -1.90 | -1.90 | 0.00 | 2.59 | 0.00 | -- | -- | 0.00 | -49.89 | -50.94 | -53.19 | -52.77 | -- | -- | -- | -1,501.78 | -- | -- | 0.00 | -- | -- | -- | 53.69 | -- | 33.34 | -- |
| Talis Biomedical Corp | 2.13m | -62.01m | 16.67m | 99.00 | -- | 0.2412 | -- | 7.81 | -34.26 | -34.26 | 1.18 | 37.93 | 0.0162 | -- | 11.92 | 21,555.55 | -46.98 | -68.18 | -51.14 | -74.22 | 98.08 | -- | -2,905.67 | -1,615.96 | -- | -- | 0.00 | -- | -55.65 | -2.24 | 45.13 | -- | -1.83 | -- |
| Aytu Biopharma Inc | 98.50m | -18.00m | 16.76m | 150.00 | -- | 0.5101 | -- | 0.1701 | -4.06 | -4.06 | 20.97 | 5.90 | 0.7224 | 2.79 | 3.59 | 656,653.30 | -13.20 | -33.56 | -25.46 | -52.81 | 63.24 | 56.89 | -18.27 | -73.81 | 0.9094 | -0.4382 | 0.3281 | -- | 11.10 | 96.56 | 84.33 | -- | -- | -- |
| VBI Vaccines Inc | 8.68m | -93.84m | 16.78m | 131.00 | -- | 1.87 | -- | 1.93 | -9.42 | -9.42 | 0.5588 | 0.3147 | 0.0717 | 1.66 | 184.72 | 66,274.81 | -76.71 | -46.58 | -143.53 | -58.62 | -44.09 | -277.46 | -1,069.29 | -2,755.98 | 0.3662 | -4.28 | 0.8709 | -- | 702.40 | 20.94 | 17.18 | -- | -32.07 | -- |
| Curative Biotechnology Inc | 0.00 | -6.02m | 16.92m | 4.00 | -- | -- | -- | -- | -0.0105 | -0.0105 | 0.00 | -0.0018 | 0.00 | -- | -- | 0.00 | -339.98 | -- | -- | -- | -- | -- | -- | -- | -- | -5.51 | -- | -- | -- | -- | -302.92 | -- | -- | -- |
| Senti Biosciences Inc | 2.56m | -92.72m | 16.93m | 48.00 | -- | 0.2527 | -- | 6.61 | -2.09 | -1.60 | 0.0577 | 1.46 | 0.0171 | -- | 6.94 | 53,354.17 | -61.76 | -- | -68.80 | -- | -- | -- | -3,620.54 | -- | -- | -- | 0.0015 | -- | -40.25 | -- | -67.94 | -- | -- | -- |
| Nascent Biotech Inc | 0.00 | -2.09m | 16.94m | -- | -- | 554.47 | -- | -- | -0.0147 | -0.0147 | 0.00 | 0.0002 | 0.00 | -- | -- | -- | -346.80 | -815.53 | -- | -- | -- | -- | -- | -548.75 | -- | -- | 0.8045 | -- | -100.00 | -- | -495.46 | -- | -- | -- |
| Trinity Biotech plc (ADR) | 56.83m | -36.87m | 17.06m | 398.00 | -- | -- | -- | 0.3002 | -17.71 | -9.31 | 12.36 | -15.67 | 0.7501 | 1.76 | 3.83 | -- | -48.66 | -19.82 | -61.89 | -28.84 | 34.22 | 39.90 | -64.88 | -28.30 | 1.27 | -1.61 | 1.77 | -- | -9.10 | -10.15 | 15.41 | -- | -31.08 | -- |
| Ibio Inc | 50.00k | -20.77m | 17.14m | 26.00 | -- | 0.7019 | -- | 342.74 | -21.91 | -27.30 | 0.0437 | 2.84 | 0.0012 | -- | 0.0129 | 1,923.08 | -48.41 | -28.09 | -113.84 | -32.63 | -- | -- | -41,546.00 | -1,467.30 | -- | -518.33 | 0.5942 | -- | -100.00 | -- | 0.9764 | -- | 42.90 | -- |
| Alterity Therapeutics Ltd (ADR) | 81.58k | -8.12m | 17.21m | 11.00 | -- | 0.8222 | -- | 210.98 | -1.97 | -1.97 | 0.0198 | 2.49 | 0.0044 | -- | 1.52 | 7,416.57 | -44.20 | -53.02 | -53.57 | -61.96 | -- | -- | -9,947.97 | -40,995.62 | -- | -- | 0.0143 | -- | 557.60 | -39.40 | -7.47 | -- | -34.88 | -- |
| Indaptus Therapeutics Inc | 0.00 | -15.42m | 17.25m | 7.00 | -- | 1.41 | -- | -- | -1.84 | -1.84 | 0.00 | 1.44 | 0.00 | -- | -- | 0.00 | -71.76 | -66.55 | -83.87 | -81.23 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -7.68 | -- | -- | -- |
| Talphera Inc | 651.00k | -10.29m | 17.31m | 15.00 | -- | 1.23 | -- | 26.59 | -0.7287 | -1.47 | 0.0457 | 0.832 | 0.0192 | -- | -- | 43,400.00 | -30.31 | -22.60 | -41.48 | -28.55 | -- | -- | -1,580.18 | -714.87 | -- | -- | 0.00 | -- | -- | -21.26 | -119.16 | -- | -34.33 | -- |
| Bioxytran Inc | 0.00 | -4.30m | 17.68m | 2.00 | -- | -- | -- | -- | -0.0297 | -0.0297 | 0.00 | -0.0017 | 0.00 | -- | -- | -- | -2,431.80 | -1,420.53 | -- | -- | -- | -- | -- | -- | -- | -7.69 | -- | -- | -- | -- | -73.71 | -- | -- | -- |
| Solarwindow Technologies Inc | 0.00 | -2.36m | 17.82m | 1.00 | -- | 2.76 | -- | -- | -0.0443 | -0.0468 | 0.00 | 0.1214 | 0.00 | -- | -- | 0.00 | -25.51 | -44.62 | -26.29 | -45.23 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 44.04 | -- | -- | -- |
| Pharmacyte Biotech Inc | 0.00 | -14.82m | 17.84m | 2.00 | -- | 0.5731 | -- | -- | -1.64 | -1.64 | 0.00 | 5.74 | 0.00 | -- | -- | 0.00 | -1.53 | -13.35 | -1.62 | -13.70 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -1.81 | -- | -- | -- |
Data as of May 03 2024. Currency figures normalised to Alterity Therapeutics Ltd's reporting currency: US Dollar USD
1.00%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Morgan Stanley & Co. LLCas of 31 Dec 2023 | 55.03k | 0.63% |
| BMO Asset Management Corp.as of 31 Dec 2023 | 14.91k | 0.17% |
| Virtu Americas LLCas of 31 Dec 2023 | 10.80k | 0.12% |
| Twin Lakes Capital Management LLCas of 31 Dec 2023 | 5.93k | 0.07% |
| Providence Capital Advisors LLCas of 31 Dec 2023 | 200.00 | 0.00% |
| Osaic Wealth, Inc. (Investment Management)as of 31 Dec 2023 | 58.00 | 0.00% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Dec 2023 | 50.00 | 0.00% |
| FSC Securities Corp.as of 30 Sep 2023 | 47.00 | 0.00% |
| Sugarloaf Wealth Management LLCas of 31 Mar 2024 | 33.00 | 0.00% |
| Woodbury Financial Services, Inc.as of 31 Dec 2023 | 23.00 | 0.00% |
More ▼
Data from 30 Sep 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
